35 Crosby Drive
United States - Map
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women. The companys Breast Health segment offers full field digital mammography, C-view, screen-film mammography, computer aided detection, Trident specimen radiography, and stereotactic breast biopsy systems; healthcome mammography, breast biopsy, and breast brachytherapy products; and breast tomosynthesis, Selenia full field digital mammography platform, SecurView workstation, MammoPad breast cushions, photoconductor coatings, and Sentinelle medical magnetic resonance imaging breast coils and workstations. Its Diagnostics segment provides APTIMA family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, Cervista HPV tests, ThinPrep system, fetal fibronectin tests, Procleix family of assays, and infectious disease and virology products. The companys GYN Surgical segment offers NovaSure system to treat women suffering from abnormal uterine bleeding; MyoSure system for the hysteroscopic removal of fibroids; and Aquilex Fluid Control System to measure the inflow and outflow of fluid from the patient during hysteroscopic procedures. Its Skeletal Health segment provides discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; Sahara clinical bone sonometers, which assess the bone density of heels; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patients extremities. Hologic, Inc. sells its products through direct sales and service forces, and a network of independent distributors and sales representatives primarily in the United States, Europe, and the Asia-Pacific. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.
|Hologic Inc.’s ISS Governance QuickScore as of Mar 1, 2014 is 9. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 10; Compensation: 9.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Glenn P. Muir ,
Chief Financial Officer and Exec. VP of Fin. & Admin.
|Mr. Mark J. Casey ,
Chief Admin. Officer, Sr. VP, Gen. Counsel and Sec.
|Mr. David P. Harding ,
Group VP of Women's Health
|Ms. Christiana Stamoulis ,
Director and Member of Corp. Devel. Committee
|Mr. Stephen P. MacMillan ,
Chief Exec. Officer, Pres and Director
|Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|